Rheumatic Disease eJournal Club

Biographies

Leonard Calabrese, DO

Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman
Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Cleveland Clinic
Cleveland, Ohio

Paul Emery, MA, MD, FRCP
Paul Emery, MA, MD, FRCP, is Arthritis Research Campaign Professor of Rheumatology and Head of the Academic Unit of Musculoskeletal Medicine at the University of Leeds, and Clinical Director of Rheumatology at the Leeds Teaching Hospitals Trust, Leeds, United Kingdom. Professor Emery's research focuses on the immunopathogenesis and therapy of rheumatoid arthritis and connective tissue diseases. He has a special interest in the factors leading to persistent inflammation and is a founding member of the Early Rheumatoid Arthritis Study (ERAS),the Leeds Early Arthritis Project (LEAP), the Yorkshire Early Arthritis Register (YEAR), and the Leeds Musculoskeletal Imaging Group. He has published over 800 peer-reviewed articles in rheumatology and musculoskeletal medicine.

Professor Emery has been a member of Senior Advisory Committees of the Royal College of Physicians, the MRCP Part 1 Board, the Special Question Group for Rheumatology and Immunology, and is Past-President of the European League Against Rheumatism (EULAR). He is Treasurer of EULAR and Chairman of the EULAR MRI Imaging Group; previously, he was member of the EULAR Scientific Committee. Professor Emery is a member of the editorial boards of Rheumatology, Arthritis and Rheumatism, Annals of the Rheumatic Diseases, Clinical and Experimental Rheumatology, Clinical Rheumatology and Modern Rheumatology, the journal of the Japanese Rheumatology Association. He is a recipient of the Roche Biennial Award in Clinical Rheumatology, the Rheumatology Hospital Doctor of the Year award 1999, and, in 2002, the EULAR Prize for his outstanding contributions to rheumatology research.

Professor Emery received his medical degree from the University of Cambridge and completed specialist accreditation in internal medicine and rheumatology. He completed his thesis on the immunopathology of rheumatoid arthritis at Guy's Hospital, London, then was Head of Rheumatology at the Walter and Eliza Hall Institute in Melbourne, Australia. He was senior lecturer in rheumatology at the University of Birmingham, United Kingdom, from 1987–1995, when he joined the University of Leeds.

Gary S. Hoffman, MD, MS
Gary S. Hoffman, MD, MS, received his medical degree from the Medical College of Virginia and pursued advanced training in Medicine and Rheumatology at Dartmouth Medical School. He is the Harold C. Schott Chair for Rheumatic and Immunologic Diseases, Founder of the Cleveland Clinic Center for Vasculitis Care and Research, Founder and past Chairman of the International Network for the Study of the Systemic Vasculitides (INSSYS), Chairman of the Department of Rheumatic and Immunologic Diseases at Cleveland Clinic and Professor of Medicine at Lerner College of Medicine.

Prior to joining Cleveland Clinic, he was the Head of Vasculitis and Related Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). Dr. Hoffman has led investigations of new therapies for the treatment of the systemic vasculitides. His work includes the coordination of INSSYS-based multi-center studies of new treatments and diagnostic tools to assess vasculitis disease activity. His laboratory is studying factors that may be involved in determining organ vulnerability and selective targeting in vasculitis.

Among the numerous awards he has received for contributions to vasculitis research are the NIH Director's Award, the NIAID Director's Award, the Wegener's Foundation Award for Excellence in Clinical Research, the William Ischmael, Pemberton Awards and the Maria and Sam Miller Clinical Research Award. He has been repeatedly listed among the "Best Doctors in America" and has also received awards for excellence in teaching medicine.

Dr. Hoffman is on the Editorial Boards of numerous rheumatology journals is the Editor of Inflammatory Diseases of Blood Vessels. Dr. Hoffman is a past member of the Board of Directors of the American College of Rheumatology, serves on The FDA Advisory Board and Boards of numerous lay organizations whose goals are to educate patients and support research in vasculitis.

Kevin L. Winthrop MD, MPH
Kevin L. Winthrop MD, MPH, is Assistant Professor of Infectious Diseases, Ophthalmology, and Public Health and Preventative Medicine at Oregon Health and Science University, Portland, Oregon. Dr. Winthrop is an infectious disease epidemiologist whose research and clinical interests include drug safety and pharmacovigilance, specifically the epidemiology, prevention, and therapy of mycobacterial and other serious infections that occur in patients with autoimmune inflammatory disease. He is the medical consultant for the Oregon Public Health Department's Tuberculosis Program, and at OHSU he operates a regional referral clinic with special emphasis on opportunistic infections of the chest. Previously, Dr. Winthrop was an epidemic intelligence service officer and a staff physician in the Division of Tuberculosis Elimination at the US Centers for Disease Control and Prevention, Atlanta, Georgia.